Results of treatment with oral citrate and pyridoxine in patients with primary hyperoxaluria type 1;Resultados del tratamiento con citrato y piridoxina en la hiperoxaluria primaria tipo i

Anales Espanoles de Pediatria

Volumn 50, Issue 4, 1999, Pages 397-401

  Castelló Girona, Francisco ^a   Riudor Taravilla, E ^a   Enriquez Civicos G ^a   Guell Torne C ^a   Fornaguera Soler, F ^a  

^a HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; PYRIDOXINE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME DEFECT; FEMALE; HUMAN; IMMUNOREACTIVITY; INFANT; KIDNEY CALCIFICATION; MALE; MOLECULAR GENETICS; NEPHROLITHIASIS; NEWBORN; NEWBORN HYPOXIA; ORAL DRUG ADMINISTRATION; OXALOSIS 1; TREATMENT PLANNING; URINARY EXCRETION; URINARY TRACT INFECTION;

CITRATES; FEMALE; HUMANS; HYPEROXALURIA, PRIMARY; INFANT, NEWBORN; KIDNEY; MALE; PYRIDOXINE; RADIOGRAPHY, ABDOMINAL;

EID: 0033030721     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Danpure CJ, Jennings PR, Watts RWE. Enzymological diagnosis of primary hyperoxaluria type I by measurement of hepatic alanine: glyoxilate aminotransferase activity. Lancet 1987; I:289-291.
2. Danpure CJ, Jennings PR, Fryer P. Primary hyperoxaluria type I: genotypic and phenotypic heterogeneity. J Inher Metab Dis 1994; 17:487-499.
3. Gibbs DA, Watts RWE. The action of pyridoxine in primary oxaluria. Clin Sci 1970; 38:277-286.
4. Will EJ, Bijvoet OL. Primary oxalosis: clinical and biochemical response to high dose pyridoxine therapy. Metabolism 1979; 28:542-548.
5. Alinei P, Guignard JP. Pyridoxine treatment of type I hyperoxaluria. N Engl J Med 1984; 311:798-799.
6. Yendt ER, Cohanin M. Respose to a physiologic dose of pyridoxine in type I primary hiperoxaluria. N Engl J Med 1985; 312:953-957.
7. Milliner DS, Eickholt JT, Bergstralh EJ. Results of long term treatment with orthophosphate and pyridoxine in patients with primary hiperoxaluria. N Engl J Med 1994; 331:1553-1558.
8. Levmann E., Hoppe B, Neuhaus T. Management of primary hyperoxaluria efficay of oral citrate administration. Pediatr Nephrol 1993; 7:207-211.
9. Kraayeveld P, Roblaen S, Wolff E. Primary hiperoxaluria type I renal ultrasound before and after treatment. Pediatr Nephrol 1997; 11:491-493.
10. Tarn AC, von Schnakenburg C, Rumsby. Primary hiperoxaluria type I: Diagnostic relevance of mutations and polymorphims in the alanine: glyoxylate aminotransferase gene (AGXT). J Inher Metab Dis 1997; 20:689-696.
11. Von Shuakenburg C, Rumsby G. Primary hyperoxaluria type 1: a cluster and new mutations in exon 78 of the AGXT gene. J Med Genet 1997; 34:489-492.
12. Hoppe B, Danpure CJ, Rumsby G. A vertical (pseudodoinmant) pattern of inheritance in the autosomal recessive disease primary hiperoxaluria type 1. Lack of relationship between genotype, enzymic phenotype and disease severity. Am J Kidney Dis 1997;29;36-40.
13. Mc Donald IC, Landrenean MD, Rohn MS. Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Ned 1989; 321:1100-1103.
14. Watts RWE, Morgan SH, Danpure CJ. Combined hepatic and renal transplantation in primary hyperoxaluria type 1: clinical reports of nine cases. Am J Med 1991; 90:179-188.
15. Broyer M, Brunner FP, Brynger H. Kidney transplantation in primary oxalosis:data from the EDTA registry. Nephrol Dial Transplant 1990; 5:332-336.
16. Werness PG, Brown CM, Smith LH. Equil 2, a basic computer program for the calculation of urinary saturation. J Urol 1985; 134:1242-1244.